Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia

Saudi Medical Journal

Volumn 25, Issue 10, 2004, Pages 1419-1422

  Ul Hassan, Zahoor ^a   Al Bahrani, Ahmad T ^a   Panhotra, Bodh R ^a  

^a KING FAHAD HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL DEPARTMENT; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INDIAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; SAUDI ARABIA; SCREENING TEST; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; WESTERN BLOTTING;

ADULT; AGE DISTRIBUTION; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAUDI ARABIA; SEX DISTRIBUTION;

EID: 7244231406     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Poiesz BJ, Rusceth FW, Gazder AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C Retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415-7419.
2. Vrielink H, Reesink HW. HTLV-I/II prevalence in different geographic locations. Transfusion Med Rev 2004; 18: 46-57.
3. Manns A, Blattner WA. The epidemiology of human T-Cell lymphotropic virus type I & II: Etiologic role in human disease. Transfusion 1991; 31: 67-75.
4. Clark J, Saxinger C, Gibbs N, Lofters W, Lagranade L, Blattner WA. Seroepidemiologic studies of human T-Cell leukemia/lymphoma virus type I in Jamaica. Int J Cancer 1985; 36: 37-41.
5. Yamaguchi K. Human T-Cell lymphotropic virus type I in Japan. Lancet 1994; 343: 213-216.
6. Hall WW, Kubo T, Lijich S, Takahashi H, Zhu SW. Human T-Cell leukemia/lymphoma virus type II (HTLV-II): Emergence of an important newly recognized pathogen. Semin Virol 1994; 5: 165-178.
7. Madeleine MM, Wiktor SZ, Goedert IJ. HTLV-I & HTLV-II worldwide distribution: Reanalysis of 4832 immunoblot results. Int J Cancer 1993; 54: 255-260.
8. Seiki M, Hattori S, Yoshida M. Human adult T-Cell leukemia virus: Molecular cloning of the provirus DNA and the unique terminal structure. Proc Natl Acad Sci USA 1982; 79: 6899-6902.
9. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T-Cell leukemia virus by blood transfusion: Seroconversion in recipients. Vox Sang 1994; 46: 245-253.
10. Hjelle B, Mills R, Mertz G, Swenson S. Transmission of HTLV-I via blood transfusion. Vox Sang 1990; 39: 119-122.
11. Abbaszadegan MR, Gholamin M, Tabatabaee A, Farid R, Houshmand M, Abbaszadegan M. Prevalence of human T-lymphotropic virus type I among blood donors from Mashhad, Iran. J Clin Microbiol 2003; 41: 2593-2595.
12. Arif M, Ramia S. Seroprevalence of human T-lymphotropic virus type I (HTLV-I) in Saudi Arabia. Ann Trop Med Parasitol 1998; 92: 503-509.
13. Bernvil SS, Anderew V, Coulter N. International forum: Saudi Arabia. Donor screening for HTLV-I in Saudi Arabia: Is it cost effective. Transfusion Sci 1997; 18: 45-47.
14. Jamjoom GA, Maatoog JA, Gazal M, Bawazeer M. HTLV-I, non-Saudi blood donors at King Fahad Hospital Jeddah. Annals of Saudi Medicine 1997; 17: 565-566.
15. Al-Jaouni SK. Seroprevalence of antibodies to human T-lymphotropic virus types I & II among Saudi Blood donors. Annals of Saudi Medicine 2000; 20: 155-156.
16. Taha MA, Bashawri LA, Ahmed MS, Ahmed MA. Prevalence of antibodies to human T-lymphotropic viruses types I and II among healthy blood donors. Saudi Med J 2003; 24: 637-640.
17. Fathalla SF, Al-Jama A, Al-Sheikh IH, Sherief IAM, Islam IAM. Seroepidemiological prevalence of HTLV-I among healthy blood donors in Eastern Saudi Arabia. Annals of Saudi Medicine 1998; 18: 366-367.
18. Lee HH, Swanson P, Rosenblatt JD, Chen J, Sherwood W, Smith D. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in USA blood donors. Lancet 1991; 337: 1435-1439.
19. The HTLV European Research Network. Seroepidemiology of human T-Cell leukemia/lymphoma viruses in Europe. J AIDS 1996; 13: 68-77.
20. Tynell E, Anderson S, Lithander M, Areneborn M, Blomberg J, Hanson HB et al. Screening of human T-Cell leukemia/lymphoma virus among blood donors in Sweden: Cost effective analysis. BMJ 1998; 316: 1417-4422.